Sirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in mice

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Shalwala, Mona ^a,b   Zhu, Shu Guang ^a,c   Das, Anindita ^a   Salloum, Fadi N ^a   Xi, Lei ^a   Kukreja, Rakesh C ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Touro College of Osteopathic Medicine   (United States)

^c GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RESVERATROL; SILDENAFIL; SIRTINOL; SIRTUIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE; IN VITRO STUDY; ISOLATED HEART; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REPERFUSION INJURY; TISSUE HOMOGENATE; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; BENZAMIDES; BLOTTING, WESTERN; CARDIOTONIC AGENTS; ENZYME ACTIVATION; MALE; MICE; MICE, INBRED ICR; NAPHTHOLS; PIPERAZINES; PURINES; REPERFUSION INJURY; SIRTUIN 1; SULFONES;

EID: 84897943786     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086977     Document Type: Article

References (23)

1. Ockaili R, Salloum F, Hawkins J, Kukreja RC (2002) Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial KATP channels in rabbits. Am J Physiol Heart Circ Physiol 283: H1263-H1269.
2. Salloum F, Yin C, Xi L, Kukreja RC (2003) Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ Res 92: 595-597. (Pubitemid 36417692)
3. Salloum FN, Abbate A, Das A, Houser JE, Mudrick CA, et al. (2008) Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol 294: H1398-H1406. (Pubitemid 351468739)
4. Das A, Xi L, Kukreja RC (2005) Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 280: 12944-12955.
5. Das A, Xi L, Kukreja RC (2008) Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem 283: 29572-29585.
6. Trapp J, Jochum A, Meier R, Saunders L, Marshall B, et al. (2006) Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition. J Med Chem 49: 7307-7316. 10.1021/jm060118b [doi]. (Pubitemid 44913391)
7. Pillarisetti S (2008) A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases. Recent Pat Cardiovasc Drug Discov 3: 156-164.
8. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, et al. (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100: 1512-1521. 01.RES.0000267723.65696.4a [pii];10.1161/01.RES.0000267723.65696.4a [doi].
9. Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J (2004) Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res 95: 971-980. 01.RES.0000147557.75257.ff [pii]; 10.1161/01.RES. 0000147557.75257.ff [doi].
10. Porcu M, Chiarugi A (2005) The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends Pharmacol Sci 26: 94-103. S0165-6147(04)00323-2 [pii];10.1016/j.tips.2004.12.009 [doi].
11. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196. 10.1038/nature01960 [doi];nature01960 [pii].
12. Pillai JB, Isbatan A, Imai S, Gupta MP (2005) Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. J Biol Chem 280: 43121-43130. M506162200 [pii];10.1074/jbc.M506162200 [doi].
13. Shinmura K, Tamaki K, Bolli R (2008) Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1. Am J Physiol Heart Circ Physiol 295: H2348-H2355. 00602.2008 [pii];10.1152/ajpheart.00602.2008 [doi].
14. Nadtochiy SM, Redman E, Rahman I, Brookes PS (2011) Lysine deacetylation in ischaemic preconditioning: the role of SIRT1. Cardiovasc Res 89: 643-649. cvq287 [pii];10.1093/cvr/cvq287 [doi].
15. Nadtochiy SM, Yao H, McBurney MW, Gu W, Guarente L, et al. (2011) SIRT1-mediated acute cardioprotection. Am J Physiol Heart Circ Physiol 301: H1506-H1512. ajpheart.00587.2011 [pii];10.1152/ajpheart.00587.2011 [doi].
16. Bradamante S, Piccinini F, Barenghi L, Bertelli AA, de Jonge R, et al. (2000) Does resveratrol induce pharmacological preconditioning? Int J Tissue React 22: 1-4. (Pubitemid 30495274)
17. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ (2000) Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 47: 549-555. S0008-6363(00)00102-4 [pii].
18. Bradamante S, Barenghi L, Piccinini F, Bertelli AA, de Jonge R, et al. (2003) Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur J Pharmacol 465: 115-123. S0014299903014419 [pii].
19. Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, et al. (2005) Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310: 314-317. 310/5746/314 [pii];10.1126/science.1117728 [doi].
20. Shalwala M, Zhu SG, Das A, Salloum FN, Xi L, et al. (2010) SIRT1 Activation Mediates Sildenafil-Induced Cardioprotection Against Ischemia/Reperfusion Injury in Mice. Circulation 122: A14584 (Abstract).
21. Zhu SG, Xi L, Kukreja RC (2012) Type 2 diabetic obese db/db mice are refractory to myocardial ischaemic post-conditioning in vivo: potential role for Hsp20, F1-ATPase delta and Echs1. J Cell Mol Med 16: 950-958. 10.1111/j.1582-4934.2011.01376.x [doi].
22. Ferrara N, Rinaldi B, Corbi G, Conti V, Stiuso P, et al. (2008) Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res 11: 139-150. 10.1089/rej.2007.0576 [doi]. (Pubitemid 351271626)
23. Paffett ML, Lucas SN, Campen MJ (2012) Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle. Vascul Pharmacol 56: 64-73. S1537-1891(11)00370-3 [pii];10.1016/j.vph.2011.11.002 [doi].